A review of published patient data from the United States, the United Kingdom, and Australia found that in ovarian cancer (12), the frequency of BRCA1 mutations in different countries ranged from 3.4% to 47%, and the frequency of BRCA2 mutations ranged from 1% to 12%. The gene discussed is BRCA2; the disease is ovarian carcinoma.